SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-23-000055
Filing Date
2023-06-15
Accepted
2023-06-14 18:47:12
Documents
13
Period of Report
2023-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flks-20230614.htm   iXBRL 8-K 66607
2 EX-10.1 salariusespp-4129x2112x032.htm EX-10.1 84321
  Complete submission text file 0001615219-23-000055.txt   304812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20230614.xsd EX-101.SCH 1926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20230614_lab.xml EX-101.LAB 23894
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20230614_pre.xml EX-101.PRE 12543
7 EXTRACTED XBRL INSTANCE DOCUMENT flks-20230614_htm.xml XML 11337
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 231015532
SIC: 2834 Pharmaceutical Preparations